abstract |
The present invention relates to compounds of the formula (I): or pharmaceutically acceptable salts thereof, wherein A, X, R1, R2, R3 and R4 are as defined herein. Methods for making the compounds and using the compounds for the treatment of diseases associated with the LRRK2 receptor, such as Parkinson's disease, are also described. |